Conference Speakers

Deborah Baron Senior Vice President, Worldwide Business Development Pfizer
Lyla Bibi Head, U.S. Healthcare Equity Capital Markets Group Goldman Sachs
Ben Cravatt, Ph.D. Professor & Gilula Chair, Chemical Biology The Scripps Research Institute
Stacy Feld, J.D. Global Head, External Scientific Innovation Johnson & Johnson Innovation
James Fraser, Ph.D. Professor & Chair, Department of Bioengineering and Therapeutic Sciences, California Institute of Quantitative Biosciences UC San Francisco
Tomotaka Goji, Ph.D. Co-Founder, Managing Partner, CEO, President & Representative Director The University of Tokyo Edge Capital Partners
Jay Hagan President, CEO & Director Ambros Therapeutics
Jim Krenn Partner & Co-Chair, Emerging Companies and Venture Capital Group Morrison & Foerster
Tim Luker, Ph.D. Vice President, Lilly Ventures, West Coast USA Head, Corp BD Eli Lilly
Sunil Patel Head of Corporate Development and Business Development & Licensing Merck
Daniel Skovronsky, M.D., Ph.D. Chief Scientific & Product Officer; President, Lilly Research Laboratories CSO & President, Lilly Research Laboratories; President, Immunology Eli Lilly
Adam Welland Counsel, Technology & Life Science Transactions Sidley Austin
Adrianne Wong, Ph.D. Senior Director, Oncology Search & Evaluation, Global Business Development Daiichi Sankyo
Michael Yee Global Head of Biotechnology Research & Senior Pharma and Biotech Analyst UBS